Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250)
South Korea flag South Korea · Delayed Price · Currency is KRW
179,900
-1,000 (-0.55%)
Feb 21, 2025, 3:30 PM KST

Sam Chun Dang Pharm. Revenue

Sam Chun Dang Pharm. had revenue of 52.38B KRW in the quarter ending September 30, 2024, with 8.13% growth. This brings the company's revenue in the last twelve months to 208.22B, up 12.75% year-over-year. In the year 2023, Sam Chun Dang Pharm. had annual revenue of 192.67B with 8.65% growth.

Revenue (ttm)
208.22B
Revenue Growth
+12.75%
P/S Ratio
19.94
Revenue / Employee
509.10M
Employees
409
Market Cap
4,184.02B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023192.67B15.33B8.65%
Dec 31, 2022177.34B10.06B6.01%
Dec 31, 2021167.27B412.57M0.25%
Dec 31, 2020166.86B-19.74B-10.58%
Dec 31, 2019186.60B26.64B16.66%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Electronics 300.87T
SK hynix 57.73T
LG Energy Solution 25.62T
Samsung Biologics 4,364.39B
Hyundai Motor Company 170.28T
Celltrion 2,876.25B
Kia Corporation 104.63T
NAVER 10.39T
Revenue Rankings